Literature DB >> 16562132

Detection of biologically active adenovirions unable to plaque in human cells.

J S Butel1, J L Melnick, F Rapp.   

Abstract

Butel, Janet S. (Baylor University College of Medicine, Houston, Tex.), Joseph L. Melnick, and Fred Rapp. Detection of biologically active adenovirions unable to plaque in human cells. J. Bacteriol. 92:433-438. 1966.-Plaque formation in green monkey kidney (GMK) cells by a defective simian virus 40-adenovirus 7 "hybrid" population (PARA-adenovirus 7) was enhanced by the addition of excess adenovirions. Adenovirus types 2, 7, and 12 were capable of providing enhancement, although none of these viruses gives rise to plaques in simian cells in the absence of PARA (particle aiding replication of adenovirus). Near maximal enhancement of the PARA plaque titer on simian cells was obtained with input multiplicities ranging from 0.02 to 0.14 plaque-forming units (PFU) of helper adenovirus per GMK cell. The PFU of helper adenoviruses tested (types 2, 7, and 12) were measured in the most sensitive assay system, human kidney cells. This input corresponded to three to nine helper virus particles per GMK cell. The majority of particles capable of enhancing plaque formation by PARA banded at a density of 1.34 in CsCl. Adenoviruses inactivated by heat or ultraviolet light were not capable of enhancing plaque formation by PARA. Highest titers were obtained when PARA and helper adenovirus were inoculated simultaneously. Inoculation of the helper adenovirus 24 hr prior to the inoculation of PARA resulted in the formation of only 50% as many plaques, and no enhanced plaques developed when the adenovirus preceded PARA by 48 hr. Conversely, the addition of adenovirus 48 hr after the inoculation of PARA initiated 56% as many plaques as simultaneous inoculation; 4% of the enhanced plaques still formed when helper virus was added as late as 5 days after inoculation of PARA. These results suggest that adenovirus particles unable to plaque on human or monkey kidney cells are nevertheless capable of interacting with PARA in simian cells, thereby facilitating replication of both particles.

Entities:  

Year:  1966        PMID: 16562132      PMCID: PMC276260          DOI: 10.1128/jb.92.2.433-438.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

1.  MIXED INFECTION WITH SIMIAN VIRUS 40 AND ADENOVIRUS 12.

Authors:  G T O'CONOR; A S RABSON; I K BEREZESKY; F J PAUL
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

2.  A method for staining virus particles and identifying their nucleic acid type in the electron microscope.

Authors:  K O SMITH; J L MELNICK
Journal:  Virology       Date:  1962-07       Impact factor: 3.616

3.  Studies on mixed infection with Newcastle disease virus. III. Activation of nonplaque-forming virus by plaque-forming virus.

Authors:  A GRANOFF
Journal:  Virology       Date:  1961-05       Impact factor: 3.616

4.  Mixed infection of HeLa cells with polioviruses types 1 and 2.

Authors:  N LEDINKO; G K HIRST
Journal:  Virology       Date:  1961-06       Impact factor: 3.616

5.  SV40-adenovirus "hybrids": presence of two genotypes and the requirement of their complementation for viral replication.

Authors:  A Boeyé; J L Melnick; F Rapp
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

6.  Studies of adenovirus-SV40 hybrid viruses. 3. Transfer of SV40 gene between adenovirus types.

Authors:  W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

7.  SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another.

Authors:  F Rapp; J S Butel; J L Melnick
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

8.  Activation of a plant virus by related incomplete nucleoprotein particles.

Authors:  H A Wood; J B Bancroft
Journal:  Virology       Date:  1965-09       Impact factor: 3.616

9.  Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population.

Authors:  J S Butel; F Rapp
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

10.  Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells.

Authors:  L A Feldman; J S Butel; F Rapp
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

View more
  9 in total

1.  Comparative studies on functions of human adenovirus type 12 and its low oncogenic mutant virions.

Authors:  H Ezoe; S Mak
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

2.  Quantitative transformation of primate cells by PARA (defective SV40)-adenovirus type 7.

Authors:  S S Layne; R Duff; F Rapp
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Defective virions in human adenovirus type 12.

Authors:  S Mak
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

Review 4.  Complementation for replication by unrelated animal viruses containing DNA genomes.

Authors:  K D Cockley; F Rapp
Journal:  Microbiol Rev       Date:  1987-12

5.  Biochemical studies on bovine adenovirus type 3. II. Incomplete virus.

Authors:  K Igarashi; Y Niiyama; K Tsukamoto; T Kurokawa; Y Sugino
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

6.  Variation in the oncogenic potential of human adenoviruses carrying a defective SV40 genome (PARA).

Authors:  F Rapp; M Jerkofsky; J L Melnick; B Levy
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

7.  Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7.

Authors:  F Rapp; S Pauluzzi; J S Butel
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

8.  Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen.

Authors:  J S Butel; M J Guentzel; F Rapp
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

9.  Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.

Authors:  Irina Tutykhina; Ilias Esmagambetov; Alexander Bagaev; Alexey Pichugin; Andrey Lysenko; Dmitry Shcherbinin; Elena Sedova; Denis Logunov; Maxim Shmarov; Ravshan Ataullakhanov; Boris Naroditsky; Alexander Gintsburg
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.